ERCC5 and colorectal cancer: In a recent study including a total of 878 colorectal cancer (CRC) patients and 884 controls, Du et al. 25 found a significant increased CRC risk for the carriers of XPG rs17655 CG/GG genotypes (OR = 1.39, 95% CI = 1.14–1.69).